Skip to Main Content
Back to News

Lobbying Update: $400,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed

None

$400,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement. General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities. Verifying Accurate Leading-edge IVCT Development (VALID) Act; all provisions of the bill. Saving Access for Laboratory Services (SALSA) Act; all provisions of the bill. Clinical trials infrastructure. General discussions regarding diagnostic reimbursement policies. FDA Final Rule on Laboratory Developed Tests (LDTs). FY26 NIH Funding. General discussions regarding government efficiency opportunities. P.L. 117-58: Infrastructure Investment and Jobs Act; provisions related to environmental monitoring. P.L. 117-169: Inflation Reduction Act; provisions related to environmental monitoring. P.L. 116-260: American Innovation and Manufacturing Act; provisions related to regulated substances. P.L. 114-182: Frank R. Lautenberg Chemical Safety for the 21st Century Act; provisions related to the use of certain chemicals. P.L. 91-604: National Ambient Air Quality Standards; provisions relating to ethylene oxide emissions. P.L 117-167: CHIPS and Science Act of 2022; provisions related to semiconductor chips and STEM education. Preparedness products and services. P.L. 91-513: Issues related to the Controlled Substances Act. General discussions around government contracting opportunities POWER Act; all provisions of the bill."

You can find more data on corporate lobbying on Quiver Quantitative.

TMO Congressional Stock Trading

Members of Congress have traded $TMO stock 14 times in the past 6 months. Of those trades, 4 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $TMO stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

TMO Insider Trading Activity

TMO insiders have traded $TMO stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.

Here’s a breakdown of recent trading of $TMO stock by insiders over the last 6 months:

  • STEPHEN WILLIAMSON (Sr. VP and CFO) has made 0 purchases and 2 sales selling 19,650 shares for an estimated $11,580,924.
  • FREDERICK M. LOWERY (Executive Vice President) sold 18,300 shares for an estimated $9,732,122
  • MARC N CASPER (Chairman & CEO) has made 0 purchases and 17 sales selling 18,000 shares for an estimated $9,326,854.
  • MICHAEL A BOXER (SVP and General Counsel) sold 3,775 shares for an estimated $2,010,537
  • GIANLUCA PETTITI (Executive Vice President) has made 0 purchases and 3 sales selling 1,000 shares for an estimated $469,100.
  • NELSON CHAI sold 16 shares for an estimated $8,449

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

TMO Hedge Fund Activity

We have seen 1,093 institutional investors add shares of TMO stock to their portfolio, and 1,208 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

TMO Analyst Ratings

Wall Street analysts have issued reports on $TMO in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Baird issued a "Outperform" rating on 07/18/2025
  • Scotiabank issued a "Sector Outperform" rating on 07/11/2025
  • Argus Research issued a "Buy" rating on 04/29/2025
  • Wells Fargo issued a "Overweight" rating on 04/24/2025
  • Evercore ISI Group issued a "Outperform" rating on 04/24/2025
  • Stifel issued a "Buy" rating on 04/24/2025
  • RBC Capital issued a "Outperform" rating on 04/24/2025

To track analyst ratings and price targets for TMO, check out Quiver Quantitative's $TMO forecast page.

TMO Price Targets

Multiple analysts have issued price targets for $TMO recently. We have seen 12 analysts offer price targets for $TMO in the last 6 months, with a median target of $570.0.

Here are some recent targets:

  • Catherine Schulte from Baird set a target price of $553.0 on 07/18/2025
  • Sung Ji Nam from Scotiabank set a target price of $590.0 on 07/11/2025
  • Dan Leonard from UBS set a target price of $460.0 on 07/09/2025
  • Vijay Kumar from Evercore ISI Group set a target price of $480.0 on 07/08/2025
  • Luke Sergott from Barclays set a target price of $450.0 on 06/24/2025
  • David Toung from Argus Research set a target price of $470.0 on 04/29/2025
  • Brandon Couillard from Wells Fargo set a target price of $570.0 on 04/24/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles